ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,522Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 534

$967K Total Retail Price of All Prescriptions

Rank: 8 out of 534

286 Patients Receiving at Least One Drug in Part D
7%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 286 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 286 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

6% of this provider’s 386 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$113 was the average price of a prescription from this provider, compared to $110 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SUBOXONE 625 26 1 20
CLOZAPINE 571 0 2 8
RISPERIDONE 398 35 3 2
TRAZODONE HCL 333 13 4 1
CITALOPRAM HBR 271 0 5 3
ABILIFY 256 12 6 9
VENLAFAXINE HCL ER 255 0 7 15
LAMOTRIGINE 239 0 8 6
SEROQUEL XR 237 0 9 32
BENZTROPINE MESYLATE 220 23 R 10 12
LITHIUM CARBONATE 206 0 11 16
OLANZAPINE 197 0 12 11
GABAPENTIN 196 0 13 17
SERTRALINE HCL 195 33 14 7
VENLAFAXINE HCL 191 0 15 47
DEXTROAMPHETAMINE-AMPHETAMINE 182 0 S2 10 16 45
TOPIRAMATE 181 12 17 31
PAROXETINE HCL 174 0 18 21
DOXEPIN HCL 159 0 19 33
FLUOXETINE HCL 151 0 20 4
PROPRANOLOL HCL 146 0 21 34
ZOLPIDEM TARTRATE 145 0 22 13
QUETIAPINE FUMARATE 141 17 23 5
CLONIDINE HCL 125 0 24 24
DIVALPROEX SODIUM ER 112 0 25 23
BUPROPION HCL SR 112 12 25 10
ZIPRASIDONE HCL 105 0 27 35
BUSPIRONE HCL 105 12 27 22
MIRTAZAPINE 100 11 29 14
LATUDA 98 0 30 57
HALOPERIDOL 93 0 31 28
CYMBALTA 93 12 31 19
OMEPRAZOLE 83 0 33 94
FLUVOXAMINE MALEATE 74 0 34 40
PERPHENAZINE 73 0 35 30
OXCARBAZEPINE 69 12 36 27
DIVALPROEX SODIUM 69 0 36 18
HYDROXYZINE HCL 64 0 R 38 54
SEROQUEL 62 0 39 25
SIMVASTATIN 61 0 40 86
LEVOTHYROXINE SODIUM 51 0 41 58
BUPROPION HCL 50 0 42 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.